About Icons

Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	The links beside this icon are links to external sites.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	A text longer than 100 characters is fully displayed or collapsed.
	The contents of the displayed table are downloaded as a file named "table.csv".

Drug Description in Trials / DrugBank / KEGG DRUG

Search results

No.

KEGG DRUG

DrugBank

Drug (Description in trials)

KEGG GENES

KEGG PATHWAY

Disease ID

1

Dalfampridine 💬
(4-Aminopyridine)

[1] Dalfampridine (4-Aminopyridine)

[4] 4-aminopyridine; Dalfampridine; FAMPRIDINA; FAMPRIDINE

[7] KCNA1,
KCNA2,
KCNA4,
KCNA6,
KCNC3,
KCND2,
KCND3 💬

Name	Full Name
KCNA1	potassium voltage-gated channel subfamily A member 1
KCNA2	potassium voltage-gated channel subfamily A member 2 isoform a
KCNA4	potassium voltage-gated channel subfamily A member 4
KCNA6	potassium voltage-gated channel subfamily A member 6
KCNC3	voltage-gated potassium channel KCNC3 isoform 1
KCND2	A-type voltage-gated potassium channel KCND2
KCND3	A-type voltage-gated potassium channel KCND3 isoform 1

[5] Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬

[2] 4, 13 💬